Nivolumab in paediatric cancer: Children are not little adults Editorial

  

Authors:	Mora, J.; Modak, S.
Title:	Nivolumab in paediatric cancer: Children are not little adults
Keywords:	dose response; drug safety; monotherapy; drug approval; note; cancer immunotherapy; pharmacodynamics; practice guideline; childhood cancer; lymphoma; drug metabolism; pediatrics; phase 2 clinical trial (topic); phase 1 clinical trial (topic); nivolumab; human; priority journal; solid malignant neoplasm
Journal Title:	Lancet Oncology
Volume:	21
Issue:	4
ISSN:	1470-2045
Publisher:	Elsevier Science, Inc.
Date Published:	2020-04-01
Start Page:	474
End Page:	476
Language:	English
DOI:	10.1016/s1470-2045(20)30086-3
PUBMED:	32192574
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082489879&doi=10.1016%2fS1470-2045%2820%2930086-3&partnerID=40&md5=57e4c7b75dacf36c02854b200aebd513
Notes:	Note -- Export Date: 1 May 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/165164